Physician profile
Christopher D Hess
NPI 1972919199
$6,008.71
in general payments reported to CMS, 2019-2025
27 companies · $1,845 in 2025
The $1,845 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $798 · 2021: $1,210 · 2022: $1,082 · 2023: $567 · 2024: $373 · 2025: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524 · Travel and Lodging: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.83 |
| Travel and Lodging | $261.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,827.25 | 2020-2025 | |
| Smith+Nephew, INC. | $918.83 | 2020-2025 | Grafix Pl, Renasys Go V2 Home, Collagenase Santyl |
| Organogenesis INC. | $832.37 | 2019-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Boston Scientific Corporation | $416.11 | 2021-2025 | Wavewriter Alpha Prime 16, Avvigo Guidance System, Mamba |
| Medtronic, INC. | $97.84 | 2025 | Inceptiv |
| Misonix INC | $97.31 | 2020-2021 | |
| Kerecis Limited | $92.39 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $89.65 | 2023-2025 | Proclaim, Axium |
| Bioventus LLC | $79.08 | 2019-2023 | |
| Stryker Corporation | $71.20 | 2025 | Augment Injectable, Fuseforce, Dart-Fire |
| Horizon Therapeutics Plc | $70.89 | 2021 | |
| Mid-Atlantic Surgical Systems, LLC | $51.20 | 2025 | |
| Nabriva Therapeutics, Plc | $49.33 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.12 | 2019 | |
| Polynovo North America LLC | $36.10 | 2024 | Novosorb Btm |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $33.23 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Abbvie INC. | $26.79 | 2022 | |
| Nevro Corp. | $24.63 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.60 | 2025 | |
| Solventum Corporation | $19.19 | 2025 | Activ.A.C. |
| Inari Medical, INC. | $19.05 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $18.43 | 2023 | Hillrom - Centrella Smart+ Bed |
| Paratek Pharmaceuticals, INC. | $16.97 | 2024 | Nuzyra |
| Ebi, LLC | $16.86 | 2025 | Biomet Ebi Bone Healing System |
| Globus Medical, INC. | $13.68 | 2024 | Harvest |
| Innovation Technologies INC | $13.61 | 2024 | Irrisept |
| Biotissue Holdings INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.